Test Price
2,800 AED✅ Home Collection Available
NXF5 Gene Genetic Test for Non-Syndromic Intellectual Disability in UAE | 2,800 AED
Executive Summary & Core Metrics
✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing
🚚 Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
📞 Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation
💳 Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
This advanced diagnostic test sequences the NXF5 gene using next-generation sequencing (NGS) technology, delivering 99.9% diagnostic sensitivity through ISO-accredited processing at DNA Labs UAE. The service includes temperature-controlled home specimen collection by trained phlebotomists, comprehensive post-test telephonic consultation for result interpretation, and direct insurance verification support. Price: 2,800 AED inclusive of all services.
Test Overview & Methodology
The NXF5 gene next-generation sequencing test provides definitive genetic confirmation of non-syndromic intellectual disability caused by mutations in the NXF5 gene. This comprehensive analysis identifies pathogenic variants across all coding exons and flanking intronic regions, enabling precise molecular diagnosis for patients with unexplained cognitive impairment and family history of X-linked intellectual disability.
| Feature | NXF5 NGS Test | Sanger Sequencing Alternative |
|---|---|---|
| Analytical Sensitivity | 99.9% with deep coverage across all exons | ~95% limited to pre-selected regions |
| Methodology | Next-Generation Sequencing (NGS) – full gene analysis | Targeted Sanger sequencing – predefined hot spots only |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Service Model | Home collection with cold-chain logistics; post-test guidance included | Typically clinic-only draw; limited interpretive support |
Physician Insight & Safety Protocols
"The NXF5 gene sequencing test offers robust diagnostic clarity for families navigating unexplained intellectual disability. However, a positive finding must be integrated with full clinical, developmental, and family history assessments. This test informs etiology but does not replace ongoing neurological or genetic counseling. Therapeutic decisions should always be guided by a multidisciplinary team."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory on Clinical Context
A pathogenic NXF5 variant confirms the molecular basis of intellectual disability in many cases, yet prognosis varies significantly based on allelic heterogeneity, modifier genes, and environmental factors. Do not discontinue or alter any prescribed medications, therapies, or educational interventions based solely on genetic results without consulting the managing physician. Genetic test results complement, not replace, standard clinical care.
Exclusion Criteria & Safety Red Flags
Contraindications for Blood Collection
- Exclusion: Acute febrile illness, severe anemia, or blood transfusion within the last 4 weeks.
- Exclusion: Inability to provide venous blood sample or written informed consent (guardian consent required for minors per UAE regulatory standards).
Emergency Red Flags
- Sudden cognitive decline, new-onset seizures, or loss of consciousness require immediate emergency medical attention — not laboratory testing. Call 998 or proceed to the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the NXF5 gene test and how is it performed?
This advanced genetic test sequences the NXF5 gene to identify mutations causing non-syndromic intellectual disability. A peripheral blood sample or FTA card is collected via our mobile phlebotomy service. DNA is extracted and analyzed using next-generation sequencing covering all coding exons and splice sites. Results are interpreted by board-certified genetics professionals and reported with variant classification per ACMG guidelines.
2. Who should consider undergoing the NXF5 gene test?
Patients with unexplained intellectual disability, developmental delay, or a family history suggestive of X-linked inheritance should pursue this test. It is particularly indicated for males with non-syndromic cognitive impairment where standard evaluations have been unrevealing. Pre-test genetic counseling is strongly recommended to discuss implications for family members and reproductive planning.
3. Is the test safe and what are the risks?
The NXF5 gene test is a routine blood draw with minimal risk — minor bruising or discomfort at the venipuncture site is the most common side effect. No fasting or medication adjustment is required. The genetic analysis itself carries no physical risk. Psychological or social risks related to genetic findings are discussed during pre- and post-test counseling sessions provided by our clinical genetics team.
4. How are results delivered and interpreted?
Results are delivered via secure electronic report within 3–4 weeks, followed by a telephonic consultation with a genetics specialist. The report includes variant pathogenicity classification, inheritance pattern, and clinical recommendations. A follow-up letter for the referring physician summarizes actionable findings. All data is handled in compliance with UAE data protection regulations.
UAE Regulatory & Data Privacy Adherence
✓ UAE REGULATORY COMPLIANCE: This test and its associated data handling procedures strictly adhere to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent frameworks follow Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | NXF5 Gene Genetic Test for Non-Syndromic Intellectual Disability |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Analysis |
| ICD-10-CM Code | F79 (Unspecified intellectual disabilities) |
| LOINC Code | 81247-9 (Intellectual disability and/or developmental delay comprehensive genetic testing panel) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians